$BOTY
LINGERIE FIGHTING CHAMPIONSHIPS, INC.

2021 Q4 Form 10-K Financial Statement

#000164033422000653 Filed on March 31, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $19.10K $95.44K $5.760K
YoY Change 231.6% 243.59% 21.26%
Cost Of Revenue $29.59K $96.25K $1.800K
YoY Change 1543.89% 248.06% -65.38%
Gross Profit -$10.49K -$809.00 $3.960K
YoY Change -364.9% -752.42% -980.0%
Gross Profit Margin -54.92% -0.85% 68.75%
Selling, General & Admin $195.2K $411.7K $63.71K
YoY Change 206.34% 76.64% 130.92%
% of Gross Profit 1608.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $195.2K $411.7K $63.71K
YoY Change 206.33% 76.64% 130.92%
Operating Profit -$205.7K -$412.5K -$59.75K
YoY Change 244.18% 77.08% 113.09%
Interest Expense $8.184M $626.7K -$3.441M
YoY Change -337.86% 130.33% 92.1%
% of Operating Profit
Other Income/Expense, Net -$3.000K -$3.111M $21.86K
YoY Change -113.72% 43.16% 179.54%
Pretax Income $7.975M -$3.524M -$3.478M
YoY Change -329.27% 46.45% 92.05%
Income Tax
% Of Pretax Income
Net Earnings $7.975M -$3.524M -$3.478M
YoY Change -329.27% 46.45% 92.05%
Net Earnings / Revenue 41754.66% -3692.06% -60389.41%
Basic Earnings Per Share
Diluted Earnings Per Share $2.364K -$1.184K -$1.487K
COMMON SHARES
Basic Shares Outstanding 3.291B shares
Diluted Shares Outstanding 8.883B shares

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.48K $34.48K $4.140K
YoY Change 732.85% 732.85% -90.53%
Cash & Equivalents $34.48K $34.48K $4.142K
Short-Term Investments
Other Short-Term Assets $7.500K $7.500K
YoY Change
Inventory
Prepaid Expenses $7.500K $0.00
Receivables
Other Receivables
Total Short-Term Assets $41.98K $41.98K $4.142K
YoY Change 913.54% 914.01% -90.52%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets -$1.00 $0.00 -$2.00
YoY Change -50.0%
TOTAL ASSETS
Total Short-Term Assets $41.98K $41.98K $4.142K
Total Long-Term Assets -$1.00 $0.00 -$2.00
Total Assets $41.98K $41.98K $4.140K
YoY Change 914.01% 914.01% -90.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $465.2K $465.2K $388.7K
YoY Change 19.68% 19.68% 79220.41%
Accrued Expenses $231.8K $231.8K $287.4K
YoY Change -19.34% -19.34% -12.03%
Deferred Revenue
YoY Change
Short-Term Debt $799.8K $799.8K $531.7K
YoY Change 50.44% 50.44% -25.54%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.841M $6.841M $5.883M
YoY Change 16.28% 16.28% 33.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.841M $6.841M $5.883M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $6.841M $6.841M $5.883M
YoY Change 16.28% 16.28% 33.39%
SHAREHOLDERS EQUITY
Retained Earnings -$11.72M -$8.198M
YoY Change 42.98%
Common Stock $3.535M $2.339M
YoY Change 51.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.799M -$6.799M -$5.879M
YoY Change
Total Liabilities & Shareholders Equity $41.98K $41.98K $4.142K
YoY Change 913.54% 914.01% -90.52%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income $7.975M -$3.524M -$3.478M
YoY Change -329.27% 46.45% 92.05%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$95.15K -$265.7K -$35.00K
YoY Change 171.86% 236.64% -25.37%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 63.50K $296.0K 38.35K
YoY Change 65.58% 652.22% -56.91%
NET CHANGE
Cash From Operating Activities -95.15K -$265.7K -35.00K
Cash From Investing Activities $0.00 0.000
Cash From Financing Activities 63.50K $296.0K 38.35K
Net Change In Cash -31.65K $30.34K 3.350K
YoY Change -1044.78% -176.68% -92.04%
FREE CASH FLOW
Cash From Operating Activities -$95.15K -$265.7K -$35.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Auditor Location
AuditorLocation
Lakewood
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
4142 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
0 USD
CY2020Q4 us-gaap Convertible Debt
ConvertibleDebt
211884 USD
CY2020Q4 boty Accounts Payable And Accrued Liabilities
AccountsPayableAndAccruedLiabilities
65108 USD
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
531674 USD
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2339101663 shares
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
231839 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
287429 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0 USD
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2339102 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
-8197588 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-6798809 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5878867 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
41981 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4142 USD
CY2020 us-gaap Revenues
Revenues
27776 USD
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
27652 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
124645 USD
CY2021 us-gaap Professional Fees
ProfessionalFees
167010 USD
CY2021 us-gaap Salaries And Wages
SalariesAndWages
120000 USD
CY2020 us-gaap Salaries And Wages
SalariesAndWages
120000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
233052 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-232928 USD
CY2020 us-gaap Interest Expense
InterestExpense
272080 USD
CY2021 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-2481400 USD
CY2020 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-1922876 USD
CY2021 boty Accrued Interest Written Off
AccruedInterestWrittenOff
0 USD
CY2020 boty Accrued Interest Written Off
AccruedInterestWrittenOff
21860 USD
CY2020 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-82659 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-2406024 USD
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
462701 USD
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
118934 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3111090 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2173096 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5878867 USD
CY2021 boty Shares Of Common Stock Issued For Exercise Of Warrants Amount
SharesOfCommonStockIssuedForExerciseOfWarrantsAmount
0 USD
CY2021 boty Shares Of Common Stock Issued For Conversion Of Debts And Accrued Interest Amount
SharesOfCommonStockIssuedForConversionOfDebtsAndAccruedInterestAmount
309054 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3523554 USD
CY2021 boty Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.00
CY2020 boty Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.00
CY2021 boty Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
2976633298 shares
CY2020 boty Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
2539232818 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-4366721 USD
CY2020 boty Repayment Of Convertible Notes And Redemption Of Warrants
RepaymentOfConvertibleNotesAndRedemptionOfWarrants
881161 USD
CY2020 boty Shares Of Common Stock Issued For Conversion Of Debts Amount
SharesOfCommonStockIssuedForConversionOfDebtsAmount
95376 USD
CY2021 us-gaap Net Investment In Lease Accrued Interest Writeoff
NetInvestmentInLeaseAccruedInterestWriteoff
110076 USD
CY2021 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option After Reclassification Adjustment Tax Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterReclassificationAdjustmentTaxAttributableToParent
2064422 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3523554 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-6798809 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3523554 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-2406024 USD
CY2021 boty Gainlossonderivativeinstrumentsnetpretax
Gainlossonderivativeinstrumentsnetpretax
-2481400 USD
CY2020 boty Gainlossonderivativeinstrumentsnetpretax
Gainlossonderivativeinstrumentsnetpretax
-1922876 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
120060 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
CY2020 boty Note Conversion Fee
NoteConversionFee
0 USD
CY2020 boty Accruedinterestwrittenoff
Accruedinterestwrittenoff
21860 USD
CY2021 boty Note Conversion Fee
NoteConversionFee
2000 USD
CY2021 boty Accrued Interest Written Off
AccruedInterestWrittenOff
0 USD
CY2021 boty Increase Decrease And Prepaid Expense
IncreaseDecreaseAndPrepaidExpense
-7500 USD
CY2020 boty Increase Decrease And Prepaid Expense
IncreaseDecreaseAndPrepaidExpense
0 USD
CY2020 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
89400 USD
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-44258 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
64614 USD
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
166990 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
153145 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-265661 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-78915 USD
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1750 USD
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
216100 USD
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
175000 USD
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
296000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
296000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39350 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
30339 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-39565 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4142 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43707 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34481 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4142 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2021 boty Debt Discount From Derivative Liabilities
DebtDiscountFromDerivativeLiabilities
296000 USD
CY2020 boty Debt Discount From Derivative Liabilities
DebtDiscountFromDerivativeLiabilities
256000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
2064422 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
82659 USD
CY2021 boty Shares Of Common Stock Issued For Conversion Of Debt And Accrued Interest
SharesOfCommonStockIssuedForConversionOfDebtAndAccruedInterest
862062 USD
CY2020 boty Shares Of Common Stock Issued For Conversion Of Debt And Accrued Interest
SharesOfCommonStockIssuedForConversionOfDebtAndAccruedInterest
95376 USD
CY2021 boty Shares Of Common Stock Issued For Exercise Of Warrants
SharesOfCommonStockIssuedForExerciseOfWarrants
267439 USD
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2021 boty Write Off Of Convertible Notes And Accrued Interest
WriteOffOfConvertibleNotesAndAccruedInterest
110076 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company continually evaluates its estimates and judgments. The Company bases its estimates and judgments on historical experience and other factors that it believes to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional information becomes known, even for estimates and judgments that are not deemed critical.</p>
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34481 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4142 USD
CY2021 us-gaap Revenues
Revenues
95436 USD
CY2020 us-gaap Revenues
Revenues
27776 USD
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
96245 USD
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
27652 USD
CY2021 us-gaap Gross Profit
GrossProfit
-809 USD
CY2020 us-gaap Gross Profit
GrossProfit
124 USD
CY2021 boty Live Events And Site Subscription
LiveEventsAndSiteSubscription
68474 USD
CY2020 boty Live Events And Site Subscription
LiveEventsAndSiteSubscription
27776 USD
CY2021 boty Sponsorship
Sponsorship
26962 USD
CY2021 us-gaap Revenues
Revenues
95436 USD
CY2020 us-gaap Revenues
Revenues
27776 USD
CY2021 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5906241545 shares
CY2020 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
13331194872 shares
CY2021 boty Related Party Balances And Transactionspolicytextblock
RelatedPartyBalancesAndTransactionspolicytextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company follows FASB ASC 850, “<em>Related Party Disclosures</em>,” for the identification of related parties and disclosure of related party transaction. (See Note 9)</p>
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
5323107 USD
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
4610130 USD
CY2021Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
248077 USD
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
51 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
51 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3535302536 shares
CY2021 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
400000000 shares
CY2021 boty Weighted Average Exercise Price
WeightedAverageExercisePrice
0.0004
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0001
CY2019Q4 boty Outstanding Warrants Balances Beginning
OutstandingWarrantsBalancesBeginning
969833333 shares
CY2019Q4 boty Outstanding Warrants Exercise Price
OutstandingWarrantsExercisePrice
0.0002
CY2020 boty Granted
Granted
4656666666 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.0001
CY2020 boty Redeemed
Redeemed
-188333333 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.0003
CY2020Q4 boty Outstanding Warrants Balances Beginning
OutstandingWarrantsBalancesBeginning
5438166666 shares
CY2021 boty Granted
Granted
400000000 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.0002
CY2021 boty Exercised
Exercised
-281500000 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.0003
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5556666666 shares
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
267438920 shares
CY2021 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
281500000 shares
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
4610130 USD
CY2021 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
-1286057 USD
CY2021 boty Reduction Of Derivative Liabilities From Exercise Of Warrants
ReductionOfDerivativeLiabilitiesFromExerciseOfWarrants
-593645 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3748333 USD
CY2021Q4 boty Closing Market Price
ClosingMarketPrice
0.0008
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5456666666 USD
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5438166666 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4444017 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1641589 shares
CY2021Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
35000 USD
CY2021Q1 boty Warrants Derivative Amount
WarrantsDerivativeAmount
265000 USD
CY2021Q1 boty Debt Instrument Aggregate Discount
DebtInstrumentAggregateDiscount
300000 USD
CY2021Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
248077 USD
CY2021 boty Reduction Of Derivative Liabilities From Written Off Of Convertible Notes
ReductionOfDerivativeLiabilitiesFromWrittenOffOfConvertibleNotes
-184721 USD
CY2021 boty Addition Of New Derivative Liabilities Upon Issuance Of Warrants As Debt Discount
AdditionOfNewDerivativeLiabilitiesUponIssuanceOfWarrantsAsDebtDiscount
296000 USD
CY2021 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
385964 USD
CY2021 boty Loss On Change In Fair Value Of The Derivative
LossOnChangeInFairValueOfTheDerivative
2095436 USD
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
5323107 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
51923 USD
CY2021Q4 boty Debt Instrument Aggregate Discount
DebtInstrumentAggregateDiscount
40000 USD
CY2021Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
9000 USD
CY2021Q4 boty Warrants Derivative Amount
WarrantsDerivativeAmount
31000 USD
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
2740 USD
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2740 USD
CY2021Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
37260 USD
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
549010 USD
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
531674 USD
CY2021 boty Sfdsf
Sfdsf
26384 USD
CY2016Q4 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
100000 USD
CY2016 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
100000 USD
CY2021 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
29403 USD
CY2020 boty Common Shares Issued For Conversion Of Debt Accrued Interest
CommonSharesIssuedForConversionOfDebtAccruedInterest
12717 USD
CY2020 boty Loss Due To Derivative Liabilities On Covertible Notes
LossDueToDerivativeLiabilitiesOnCovertibleNotes
-159280 USD
CY2021 boty Loss Due To Derivative Liabilities On Warrants
LossDueToDerivativeLiabilitiesOnWarrants
-385964 USD
CY2020 boty Loss Due To Derivative Liabilities On Warrants
LossDueToDerivativeLiabilitiesOnWarrants
-253849 USD
CY2021 boty Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants
GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants
-2095436 USD
CY2020 boty Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants
GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants
-1509747 USD
CY2021 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-2481400 USD
CY2020 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-1922876 USD
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
465168 USD
CY2020Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
388668 USD
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
3083362 USD
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2700062 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
647506 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
567013 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
647506 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
567013 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2021Q4 boty Net Operating Loss Carryforward
NetOperatingLossCarryforward
3000000 USD
CY2021 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
begin to expire between 2034 and 2037
CY2021 boty Net Operating Loss Carry Forwards Annual Limitation
NetOperatingLossCarryForwardsAnnualLimitation
0.50 pure

Files In Submission

Name View Source Status
0001640334-22-000653-index-headers.html Edgar Link pending
0001640334-22-000653-index.html Edgar Link pending
0001640334-22-000653.txt Edgar Link pending
0001640334-22-000653-xbrl.zip Edgar Link pending
boty-20211231.xsd Edgar Link pending
boty-20211231_cal.xml Edgar Link unprocessable
boty-20211231_def.xml Edgar Link unprocessable
boty-20211231_lab.xml Edgar Link unprocessable
boty-20211231_pre.xml Edgar Link unprocessable
boty_10k.htm Edgar Link pending
boty_10k_htm.xml Edgar Link completed
boty_ex101.htm Edgar Link pending
boty_ex101img1.jpg Edgar Link pending
boty_ex101img10.jpg Edgar Link pending
boty_ex101img11.jpg Edgar Link pending
boty_ex101img2.jpg Edgar Link pending
boty_ex101img3.jpg Edgar Link pending
boty_ex101img4.jpg Edgar Link pending
boty_ex101img5.jpg Edgar Link pending
boty_ex101img6.jpg Edgar Link pending
boty_ex101img7.jpg Edgar Link pending
boty_ex101img8.jpg Edgar Link pending
boty_ex101img9.jpg Edgar Link pending
boty_ex102.htm Edgar Link pending
boty_ex102img37.jpg Edgar Link pending
boty_ex102img38.jpg Edgar Link pending
boty_ex102img39.jpg Edgar Link pending
boty_ex102img40.jpg Edgar Link pending
boty_ex102img41.jpg Edgar Link pending
boty_ex102img42.jpg Edgar Link pending
boty_ex102img43.jpg Edgar Link pending
boty_ex102img44.jpg Edgar Link pending
boty_ex102img45.jpg Edgar Link pending
boty_ex102img46.jpg Edgar Link pending
boty_ex102img47.jpg Edgar Link pending
boty_ex102img48.jpg Edgar Link pending
boty_ex102img49.jpg Edgar Link pending
boty_ex103.htm Edgar Link pending
boty_ex103img53.jpg Edgar Link pending
boty_ex103img54.jpg Edgar Link pending
boty_ex103img55.jpg Edgar Link pending
boty_ex103img56.jpg Edgar Link pending
boty_ex103img57.jpg Edgar Link pending
boty_ex103img58.jpg Edgar Link pending
boty_ex103img59.jpg Edgar Link pending
boty_ex103img60.jpg Edgar Link pending
boty_ex103img61.jpg Edgar Link pending
boty_ex103img62.jpg Edgar Link pending
boty_ex103img63.jpg Edgar Link pending
boty_ex103img64.jpg Edgar Link pending
boty_ex103img65.jpg Edgar Link pending
boty_ex103img66.jpg Edgar Link pending
boty_ex103img67.jpg Edgar Link pending
boty_ex103img68.jpg Edgar Link pending
boty_ex103img69.jpg Edgar Link pending
boty_ex103img70.jpg Edgar Link pending
boty_ex103img71.jpg Edgar Link pending
boty_ex103img72.jpg Edgar Link pending
boty_ex103img73.jpg Edgar Link pending
boty_ex103img74.jpg Edgar Link pending
boty_ex103img75.jpg Edgar Link pending
boty_ex103img76.jpg Edgar Link pending
boty_ex103img77.jpg Edgar Link pending
boty_ex103img78.jpg Edgar Link pending
boty_ex103img79.jpg Edgar Link pending
boty_ex104.htm Edgar Link pending
boty_ex104img10.jpg Edgar Link pending
boty_ex104img11.jpg Edgar Link pending
boty_ex104img12.jpg Edgar Link pending
boty_ex104img13.jpg Edgar Link pending
boty_ex104img14.jpg Edgar Link pending
boty_ex104img15.jpg Edgar Link pending
boty_ex104img16.jpg Edgar Link pending
boty_ex104img17.jpg Edgar Link pending
boty_ex104img18.jpg Edgar Link pending
boty_ex104img19.jpg Edgar Link pending
boty_ex104img2.jpg Edgar Link pending
boty_ex104img20.jpg Edgar Link pending
boty_ex104img21.jpg Edgar Link pending
boty_ex104img22.jpg Edgar Link pending
boty_ex104img23.jpg Edgar Link pending
boty_ex104img24.jpg Edgar Link pending
boty_ex104img25.jpg Edgar Link pending
boty_ex104img3.jpg Edgar Link pending
boty_ex104img4.jpg Edgar Link pending
boty_ex104img5.jpg Edgar Link pending
boty_ex104img6.jpg Edgar Link pending
boty_ex104img7.jpg Edgar Link pending
boty_ex104img8.jpg Edgar Link pending
boty_ex104img9.jpg Edgar Link pending
boty_ex311.htm Edgar Link pending
boty_ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending